Overview
An Overview of Stem Cells
Explore the science, applications, and benefits of stem cells for advanced healthcare solutions.
Related: How they work • Clinical benefits
Foundation
What are stem cells?
Stem cells are at the foundation of regenerative medicine, offering a natural way to repair, regenerate, and restore damaged tissues. With their unique properties of self-renewal and the ability to differentiate into specialized cells, stem cells hold invaluable potential in modern medicine. For medical professionals, understanding the basics of stem cells, the types, mechanisms, and clinical applications, along with the current state of research, is essential for navigating this rapidly evolving field.
Stem cells are programmed to secrete growth factors, signaling molecules and cell communication signals that are involved in regeneration and repair of specific tissues. For example, cardiac progenitor cells get attracted towards the heart by following distress signals secreted by the damaged areas of the tissue and repair that organ.
Stem cells exist in all multicellular organisms and play a critical role in development, growth, and tissue repair. Their applications range from fundamental research to clinical therapies, targeting injuries, degenerative diseases, and even certain forms of cancer.
| Self-Renewal | Differentiation |
|---|---|
| Stem cells can divide and produce identical copies over extended periods. | They can develop into specific cell types, such as muscle, bone, or nerve cells, depending on the body's needs. This ability to repair and regenerate tissues makes them invaluable for therapeutic applications. |
Classification
Types of stem cells
From perinatal mesenchymal lines to pluripotent lines-each category carries distinct origins, potency, and clinical context. We exclusively offer MSCs, which are by far the most potent, versatile, and ethically sourced type of stem cell.
Perinatal Stem Cells (MSCs)
Source: Derived from perinatal tissues like Umbilical Cord Tissue, placenta, and amniotic fluid, collected immediately after birth.
Potency: Multipotent, able to differentiate into various cells such as bone, cartilage, and fat.
Applications and Ethical Advantage
- They are effective for immune modulation and tissue regeneration and widely researched for therapeutic uses.
- Perinatal MSCs are ethically favorable as they are obtained from tissues typically discarded after childbirth.
Induced Pluripotent Stem Cells (iPSCs)
Source: Created by reprogramming adult cells, such as skin cells, into a pluripotent state.
Potency: Pluripotent, with the ability to differentiate into nearly any cell type.
Advantages and Limitations
- iPSCs offer an ethical alternative to ESCs, as they do not require embryos.
- However, they face challenges related to stability and potential mutations, which must be addressed before widespread clinical use.
Adult Stem Cells (ASCs)
Source: Found in tissues like bone marrow, blood, fat, and muscle, often referred to by their tissue origin (e.g., hematopoietic stem cells for blood).
Potency: Multipotent, meaning they can differentiate into a limited number of cell types within a specific tissue family.
Applications
- Blood disorders (e.g., bone marrow transplants)
- Orthopedic injuries
- Some autoimmune conditions
- Fewer ethical concerns and are widely accepted in both research and clinical settings
Embryonic Stem Cells (ESCs)
Source: Derived from embryos, typically created through in vitro fertilization and not intended for implantation.
Potency: Pluripotent, meaning they can become almost any cell type in the body.
Ethical and Regulatory Concerns
- Derived from human embryos, raising ethical and moral questions.
- Their usage is highly regulated, making them less commonly applied in clinical settings.
Quality
How we source and screen
Every criterion reflects our commitment to donor safety, tissue integrity, and clinical-grade consistency.
Young, Healthy Donors: All tissue comes from carefully screened donors aged 18-28 who have given informed consent.
Rigorous Screening Process: 3-generation family history checks, comprehensive maternal blood work, and normal female karyotyping.
Pathogen-Free Verification: Thorough testing for blood-borne pathogens, heritable and non-heritable conditions.
Pre-Pandemic Birth Origin: All umbilical cord tissue sourced from pre-COVID births for additional safety assurance.
Controlled Collection: Exclusively from healthy C-section births to ensure optimal tissue quality.
Superior Processing: DMSO-free and bovine serum-free culture media with NO animal-derived products.
Added Safety: Tissue exclusively from unvaccinated mothers under cGMP certified conditions.
Exceptional Quality: Up to 98% post-thaw viability with our premium cells reaching 95-98% viability
Introduction
Introduction: The Akira Biotech Platform
Akira Biotech LLC has built one of the most comprehensive regenerative medicine product portfolios in the world, anchored on a single, rigorously controlled biological starting material: Umbilical Cord Tissue–Wharton's Jelly derived Mesenchymal Stem Cells (UCT-WJ-MSCs) isolated exclusively from thoroughly screened donors. Every product in the Akira portfolio — whether a differentiated cell line, an exosome matrix, a secretome preparation, or isolated mitochondria — traces its biological origin to this founding cell type.
Related: How they work • Clinical data
Wharton's Jelly
Why Wharton's Jelly MSCs?
Wharton's Jelly (WJ) is the gelatinous connective tissue of the umbilical cord. It harbors a uniquely primitive population of MSCs that display characteristics intermediate between fetal and adult stem cells. WJ-MSCs express the canonical MSC surface markers (CD90⁺, CD73⁺, CD105⁺) while being negative for hematopoietic markers (CD34⁻, CD45⁻, HLA-DR⁻). Critically, they express pluripotency-associated transcription factors (Oct-4, Sox-2, Nanog) at higher levels than adult bone marrow or adipose-derived MSCs — conferring superior proliferative capacity, telomere length, and differentiation range.
Peer-reviewed studies confirm that WJ-MSCs exhibit lower immunogenicity than adult MSCs, with near-absent MHC Class II expression enabling safe allogeneic use without HLA matching or immunosuppression in most protocols. A landmark review by Dominici et al. and subsequent studies confirm the MSC marker constellation; a 2020 review in Cells demonstrated WJ-MSC paracrine outputs (IL-10, TGF-β, IDO, PGE2) exceed those of bone marrow counterparts across immunomodulatory assays.[^1]
Manufacturing Standard
Akira's Manufacturing Standard
| Parameter | Akira Biotech Specification |
|---|---|
| Donor Age | First-pregnancy mothers, 18–29 years |
| Delivery Method | Elective C-section only (controlled environment) |
| Screening | 3-generation family history, comprehensive maternal bloodwork, normal female karyotype (46,XX) |
| Passage | Maximum P2 (Passage 2) — preserves telomere length & potency |
| Cryopreservation | Glucose-based, DMSO-free medium |
| Post-Thaw Viability | >95% by trypan blue exclusion; >98% in premium batches |
| Manufacturing Standard | cGMP-compliant facility |
| Culture Media | Bovine serum-free, animal-derived product-free |
| QC Testing | Flow cytometry (CD90, CD73, CD105 positive; CD34, CD45, HLA-DR negative); mycoplasma; sterility; endotoxin |
| Differentiation Confirmation | Lineage-specific markers verified by immunofluorescence and qPCR prior to release |